Ueli Studer

Risk of Osteonecrosis of the Jaw Under Denosumab Compared to Bisphosphonates in Patients With Osteoporosis

Judith Everts‐Graber, Daniel Lehmann, John-Patrik Burkard et al. · Journal of Bone and Mineral Research · 2020 · 102 citations · Full text

Medicine, Oral Radiology, Bone Metabolism +14

A Single Infusion of Zoledronate in Postmenopausal Women Following Denosumab Discontinuation Results in Partial Conservation of Bone Mass Gains

Judith Everts‐Graber, Stephan Reichenbach, Hans Rudolf Ziswiler et al. · Journal of Bone and Mineral Research · 2020 · 96 citations · Full text

Medicine, Endocrinology, Bone Augmentation +16

Risk factors for vertebral fractures and bone loss after denosumab discontinuation: A real-world observational study

Judith Everts‐Graber, Stephan Reichenbach, Brigitta Gahl et al. · Bone · 2020 · 51 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17

Effects of zoledronate on bone mineral density and bone turnover after long-term denosumab therapy: Observations in a real-world setting

Judith Everts‐Graber, Stephan Reichenbach, Brigitta Gahl et al. · Bone · 2022 · 29 citations · Full text

Medicine, Endocrinology, Bone Metabolism +15

Incidence of Atypical Femoral Fractures in Patients on Osteoporosis Therapy—A Registry‐Based Cohort Study

Judith Everts‐Graber, Harald Bonél, Daniel Lehmann et al. · JBMR Plus · 2022 · 23 citations · Full text

Medicine, Orthopedic Surgery, Bone Metabolism +15